{
    "id": "qdqwr76dk3leuddx5znlujowbwpltt5b",
    "title": "Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization",
    "info": {
        "author": [
            "Mehmet G\u00f6nen, Department of Information and Computer Science, Aalto University"
        ],
        "published": "Oct. 23, 2012",
        "recorded": "September 2012",
        "category": [
            "Top->Computer Science->Machine Learning->Bayesian Learning",
            "Top->Computer Science->Machine Learning->Kernel Methods",
            "Top->Biology"
        ]
    },
    "url": "http://videolectures.net/mlsb2012_gonen_target/",
    "segmentation": [
        [
            "This is the outline."
        ],
        [
            "For my talk first I will introduce the problem and give the motivation.",
            "Then I will describe the materials that we used for the.",
            "Algorithim and I will briefly describe earlier approaches earlier machine learning approaches than I will describe.",
            "Our method then I will conclude with results on some future work."
        ],
        [
            "OK, why do we want to estimate drug target predict interactions?",
            "Because we can modulate functions of the proteins using drugs and we have two information sources.",
            "We have a growing knowledge of chemical space of drugs and genomic space of proteins due to high throughput screening assays and also high throughput genomic projects.",
            "But the problem is that we have a limited knowledge about relationship between these two spaces.",
            "And This is why we need some computational methods for this prediction problem."
        ],
        [
            "And also another problem is that we have some existing databases, but these databases only contains contain experimentally validated interactions.",
            "And of course these are.",
            "These contain missing interactions and that's why we need computational methods for identifying interactions, and this will bring 2 advantages.",
            "First, we can guide biologists towards new predictions, or we can provide supporting evidence for their experimental results."
        ],
        [
            "OK, basically traditional approaches can be categorized into three main groups.",
            "First one is knocking simulations, but this hasn't disadvantage of structural information requirements and for some protein families we don't have these in formation and that's why this is not applicable to all proteins.",
            "And the second category is ligand based approaches and is in this approach we have to have a significant number of.",
            "The interactions for each target protein and this may not be possible for all proteins, and the third one literature takes mining an.",
            "In this approach we can only predict interactions that are.",
            "Validated in biological publications and the other thing is other problem for this approach is that most of the time they use different naming practices.",
            "So it is very hard to mine these textual data."
        ],
        [
            "And that's why we have machine learning methods for this problem, and we have three input sources, input data sources for these algorithms.",
            "The first one is chemical properties of drugs and the second one is genomic properties of target proteins, and we also have a partial knowledge about the interaction network.",
            "We only know experimentally validated interactions.",
            "And most of the machine learning algorithms have these underlying hypothesis.",
            "Similar drug compounds are likely to interact with similar target proteins, and I underline these similar words because these similarities can be encoded using kernel functions because kernel functions mean they solve formulating similarities.",
            "And if you have two kernel functions, one of them for drugs and one of the other one is for.",
            "Proteins we can easily model the similarities."
        ],
        [
            "OK, in this Saturday we used four important protein families.",
            "These are enzymes, ion channels G protein coupled receptors are nuclear receptors.",
            "These four protein families are particularly particularly important because they are mostly related to diseases and we will solve these interaction prediction problem for these four important families."
        ],
        [
            "And we used for data sets from an earlier study and.",
            "The largest one is enzyme data set, and it contains more than 400 trucks and more than 600 proteins and smallest one is nuclear receptors.",
            "It contains 54 drugs and 26 proteins and if you look at the number of interactions it changed with the database.",
            "But if you look at the ratio of interactions ratio of the experimental validated interactions to the total possible number of interactions, we see that.",
            "Enzyme data set has possibly quote more than quarter million interactions and we only know 3000 of them.",
            "An it corresponds to around 1% and for the nickel receptors, the experimental validates the interactions amount to almost 7%, and as you can see, these interaction networks are very sparse.",
            "OK."
        ],
        [
            "So as I mentioned earlier, we have three information sources.",
            "The first one is drugs and for the drugs we have very basic similarity function which is called SIM comp and it basically represents the drugs."
        ],
        [
            "As graphs and we had a fixed set of substructures, we have fixed Dictionary of substructures and they look for these substructures in each track and at the end we can represent each track as a binary vector, whether each at each position we have binary values.",
            "Whether these substructure exist in this drug or not and at the end we can have two binary vectors.",
            "When we are calculating the similarity between two drugs.",
            "And the similarity between two dots is the number of the ratio of common substructures.",
            "Basically this similarity gives us score between zero and one.",
            "And of course the similarity between the same drugs, the similarity.",
            "Is equal to 1 an if they don't have any common substructure, the similarity will be 0."
        ],
        [
            "And the second you formation sources genomic data.",
            "We have target proteins and again we are using second space similarity because sequence space similarity can be calculated for each protein family.",
            "It is the most basic simulator.",
            "Tehran.",
            "In this study we used Smith Waterman scored and in this similarity measure proteins are represented as."
        ],
        [
            "And we know it sequences.",
            "For example, each protein has citrulline consisting of these 20 letters for amino acids, and attend the similarity between two proteins can be calculated as.",
            "The normalized Symmetry Waterman score, and again this similarity score will give us a value between zero and one if they are perfectly similar.",
            "This will be one, and if they are not similar at all this will be 0."
        ],
        [
            "And the 30 formation source may be the most informative one.",
            "Is the interaction data network and we have and the drugs an anti targets.",
            "And we have two sets of objects and at the end we are given a set of experimental validated interactions.",
            "We represent these network as a binary adjacency matrix and each entry is plus one.",
            "If the corresponding tracker is interacting with the corresponding target protein and minus one otherwise, I am using this plus 1 -- 1 because we will be modeling the problem as a binary classification problem.",
            "But for example, if you remember the keynote from yesterday, it is also possible to formulate this problem as a one class classification problem, But in this current work we formulate the problem as binary classification problem."
        ],
        [
            "And Atlantis, we have a computational model we want to achieve 2 main goals.",
            "The first one is we want to be able to.",
            "Do out of sample predictions.",
            "For example, if you are given a new drug, we want to estimate the interacting proteins from the training data.",
            "Or if you are given a new target protein, we want to estimate interacting tracks from the training data.",
            "Or the hardest problem is that we are given a new drug and then you target protein which are not seen during trainings and we want to estimate the interaction.",
            "Or between these two objects, this is the hardest case, of course.",
            "Out of these three and second prediction problem is that we want to complete this given interaction in network because we only know the experimentally validated interactions which may not be complete and we want to fill this matrix."
        ],
        [
            "OK, I would like to briefly mention previous machine learning approaches.",
            "The first one is pairwise kernel methods.",
            "In these methods we have two similarity functions.",
            "Chemical similarity between drugs and genomic similarity between targets and.",
            "We basically describer pairwise kernel function between drug target pairs and we do standard kernel based classification or regression.",
            "It doesn't matter if you have a kernel function between pairs an if you have the target output we can do any regulation or binary classification, But the problem is that we have too many pairs.",
            "For example, if you have anti drug anti proteins we have this many.",
            "Possible pairs and we have these storage complex tatiane this quaranti square an if you use standard kernel methods we will have these Andy Coop anti crypto time complexity.",
            "You remember the enzyme data set.",
            "We have quarter million possible pairs, which corresponds to training a kernel based algorithm which has quarter million training data."
        ],
        [
            "And the second approach is bipartite graph inference.",
            "Basically, these methods Maps drugs and target proteins into a common subspace called parallel park pharmacological space an in this space.",
            "We calculated distance or similarity between drugs and target pairs an.",
            "For example, if the distance between a particular pair is smaller than a threshold, we label them as interacting."
        ],
        [
            "And the third approach is matrix factorization methods.",
            "These methods are.",
            "Basically used for recommender systems.",
            "For example, if you know, do a popular Netflix movie recommendation.",
            "Problem, the idea is we have users and we have items and some users rated some items and we have a partial rating matrix and we want to complete this rating matrix.",
            "But the problem is that."
        ],
        [
            "We cannot do out of sample prediction in a simple sense.",
            "For example, if you have this many users and this many movies and this is the incomplete rating matrix and we want to feel this question marks with our predictions, this is possible using traditional matrix factorization methods.",
            "But when we have any users or anything.",
            "Movie we cannot estimate the ratings because we don't have any latent components for NIV movie or NIV users.",
            "And in that case this problem.",
            "This formulation can solve one of the prediction problems, but cannot solve out of sample prediction."
        ],
        [
            "OK, and this lights is the main slide that explains our proposed method.",
            "Basically we have three information sources and drug kernel, protein, kernel and interaction network given interaction, network and the first we need a projection matrix that Maps these drugs into a low dimensional space and we need another projection mattress for the proteins and again we mapped onto the same low dimensional space.",
            "And at that, that product inner products between drugs and proteins will give us predicted output and we have another binary classification step after the score calculation.",
            "And basically I can summarize the method as a hybrid method which is composed of three main elements.",
            "The first one is kernel based nonlinear dimensionality reduction.",
            "We have two kernels and we are doing kernel based dimensionality reduction.",
            "In in part A and we have a matrix factorization model in Part B, an import CV have a binary classification model and at that this will solve interaction prediction problem as a binary classification task.",
            "Anne.",
            "What if we are given a new drug?",
            "Basically, if you are given an IV drug, this corresponds to a new column to this drug kernel matrix and we can calculate a new column for these latent right components than we can take the product between these column and these metrics and we can easily calculate the prediction scores between all possible protein drug pairs."
        ],
        [
            "OK, this is a graphical and probabilistic model for the algorithm.",
            "I am only showing.",
            "Drug part because it is symmetric and we have the same model on the other side with different model parameters and the basic point here is that we have only gamma distribution and normal distribution which are standard probability distributions and and as we will see next doing inference for this model is very easy because of these full conjugacy."
        ],
        [
            "And the exact inference for this probabilistic model is intractable.",
            "We can use of course, very simple Gibbs sampling approach, But this is computationally expensive.",
            "An instead with if we follow the different approach and use the variational bias approximation.",
            "And basically we are using a lower bound on the marginal likelihood using some ansamble of post."
        ],
        [
            "Terriers are basically we use the mean field approximation we.",
            "Interpret all random variables and latent variables as different posteriors and attempt we have model parameters and these.",
            "Latent components for our model and we are using these Yongsan senior quality too.",
            "Find that.",
            "Find find it or put bound for these marginal likelihood lower bound for the sorry lower bound for the marginal life quote."
        ],
        [
            "I am displaying these equations because maybe this is too technical, but you can find the details in the paper, but the basic method basic idea is that we have closed form update equations for all of."
        ],
        [
            "Model parameters an AT and we have a very simple procedure we are updating at each iteration we are updating track related the rivals.",
            "Rotate related variables and interaction scores and at the end we will have these model parameters after convergence."
        ],
        [
            "OK, I will.",
            "I didn't give details about 3 experimental scenarios.",
            "The first one is exploratory data analysis.",
            "This can be used by biologists to do some analysts on the given interaction network.",
            "The second one is doing predictions for out of sample drugs and the third one is predicting unknown interactions completing the missing edges."
        ],
        [
            "OK, if you look at the interaction.",
            "Good enough for 2 dimensional case.",
            "This is nuclear receptor data set which is the smallest data set that we used becausw.",
            "We use this for visualization because it has few samples and it is easy to visualize and if you look at the two dimensional embedding, this is basically a by part.",
            "This should be a bipartite graph and we don't use this prior information and at the end we see that our algorithm is able to capture this bipartite.",
            "Nature because on one side we have drugs and on the other side we have proteins and this dashed line is the interactions in the training data and these fault lines are the predicted once out of our embedding.",
            "This is also same for.",
            "Out of sample prediction for proteins, you should notice that this is an arbitrary rotation.",
            "We can easily rotate and find a similar graph like this."
        ],
        [
            "OK, there are some important observations.",
            "First, our algorithm successfully captures the bipartite nature.",
            "We didn't give this specific information to the algorithm, but as a result of the influence we found out, we find that the resulting embedding is a bipartite graph, and dashed lines are connected.",
            "Connect nearby drugs, which is reasonable and also out of sample held out.",
            "Interactions are.",
            "Observed for nearby proteins.",
            "This may not be enough for prediction because we are using 2 dimensions, but this can be used for exploratory data analysis by biologists."
        ],
        [
            "OK, we also did some out of sample prediction using five replications of five 5 fold cross validation and we see that our algorithm.",
            "I was significantly better on two datasets, especially on ion channels and G protein coupled receptors around 10% and 5% in terms of area under the Roc curve and the results are similar for also area under the precision recall curve."
        ],
        [
            "And also we did some experiments to see the effect of the number of latent dimensions.",
            "We changed the number of dimensions from 5 to 25.",
            "As you can see, for the smallest network for the nuclear receptor data set, the dimensionality is not important because the network is so small even with five dimensions we get a good area under the curve value, but for the other data set.",
            "Performance improved.",
            "Then we increase the number of dimensions.",
            "We didn't exploit this idea, but we have a full Bayesian model.",
            "We can also learn the optimal number of latent dimensions using automatic relevance determination and we will investigate this issue later."
        ],
        [
            "OK, maybe the most important part of the experiment is this predicting unknown interactions of a given network, because for example, for the enzyme data set we have 3000 experimental validated interactions out of quarter million possible interactions, and we did an experiment like this.",
            "We train our model for the given interaction network and we rank noninteracting drug target pace with respect to.",
            "Predictions, of course, and we check predicted interactions manually from latest online versions of these three databases, and we see that if you pick top five predicted interactions for each data set, we see that 16 out of 20 predictions is reported in at least one."
        ],
        [
            "Database, as I mentioned earlier, for example for the enzyme data set, we have 3000 interactions.",
            "Experimental validates the interactions and we have this many non interacting pairs and if we rank this calls for these noninteracting kuansan.",
            "If you look at the top five we see that four of them are reported in this in at least one of these databases.",
            "And the table is very similar for the other datasets.",
            "Also an you can find you can find others tables in the paper."
        ],
        [
            "OK, in order to someone to summarize our.",
            "Contribution we have a novel Bayesian formulation, which is the first fully probabilistic formulation for this problem.",
            "Basically, it combines three basic machine learning algorithm in a principled manner and we have a.",
            "We had empirical evidence on 4 drug target interaction networks."
        ],
        [
            "And we had a very efficient variational approximation.",
            "For example, for the enzyme data set, it takes minutes to find the model parameters and met up implementation is available on my website.",
            "And for the future work we are planning to extend the model for multiple data sources.",
            "For example, we can use.",
            "Different chemical descriptors for drugs and, for example, we can also include structural descriptors for target proteins, and that's it.",
            "Thank you very much.",
            "Thank you very much so we have time for a few questions.",
            "This.",
            "In practice, there are many situations out of sample predictions and missing interaction directions.",
            "As you mentioned in this right in this talk.",
            "So I think you should perform cross validations.",
            "Which is designed for each stations.",
            "OK, you mean you mean leave one out prediction right?",
            "But in this talk you should only one.",
            "OK, let me show you the game.",
            "Yeah, how did you split direct target peers?",
            "OK here between here.",
            "Basically I am leaving 20% of the drugs out for each replication.",
            "I am basically discarding 20% of the rolls out for training data an I'm training the model done doing the prediction for the whole missing rows.",
            "It is harder than live on out prediction because I am missing whole rows instead of single entries.",
            "If you look at these good off, let me show you.",
            "OK, this is."
        ],
        [
            "Our training interaction network and for cross validation I am cutting 20% of these metrics out an I'm doing training for the remaining 80% and I'm going to prediction for the remaining 20%.",
            "Thank you, OK. OK, so there's one more question.",
            "For the similarity between proteins, you're just using sequence, yes?",
            "I wonder in their approaches where folks have used structure information.",
            "The proteins.",
            "So I was wondering if you were to compare for the subset of proteins for which."
        ],
        [
            "Structure is available if you could compare your method versus using 3D structure to determine how much you missing when you do not use structure information.",
            "Yes, exactly this is one of our future plans.",
            "For example, for these datasets.",
            "Unfortunately for these, for example, G protein coupled receptors.",
            "We don't have most for most of them we don't have the structure information as you suggested.",
            "For some of them we have the structure information and we can get a subset of these datasets.",
            "And do the prediction using structural information.",
            "Yes, and this is one of our future plans.",
            "Would it be possible to include also side effect information and through your approach?",
            "It is not very easy cause for the side effect I guess we should have a proper kernel function an if you have a.",
            "If we can device a good kernel function.",
            "Yes of course and.",
            "Instead of using a single.",
            "Instead of using a single kernel for drugs, we can include multiple ones and also for the same for proteins.",
            "Yes, we can include, but we should have a good kernel function for this.",
            "OK um.",
            "So maybe just a comprehension questions.",
            "What was it anyway?",
            "So how does it scale with the number of factors which you have?",
            "So just sort of computational complexity.",
            "OK, basically, computational complexity of our algorithm depends on these matrix inversion an if you look at these are our AP is only in one of these inversions.",
            "Basically linearly scales with the number of latent components.",
            "An if, for example, if you have these results for five components and 25 components.",
            "And the time required for 25 component is almost five times OK of the time required for five components.",
            "It's case linearly with the number of components and the original question was so, so the negative labeled data.",
            "So that's that's known to not interact.",
            "Well, that is not known to interact, so that's actually they are not known to interact, but we interpret them as negatively labeled.",
            "But as I mentioned earlier, we are using your matrix factorization model, and we can easily.",
            "Use.",
            "Damn as missing data and we can only concentrate on the known interactions.",
            "We also tried this approach and area under the curve.",
            "Values are very similar.",
            "Basically it doesn't hurt to include them as negatively labeled data.",
            "Good, OK, let's thank the speaker again."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This is the outline.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "For my talk first I will introduce the problem and give the motivation.",
                    "label": 0
                },
                {
                    "sent": "Then I will describe the materials that we used for the.",
                    "label": 0
                },
                {
                    "sent": "Algorithim and I will briefly describe earlier approaches earlier machine learning approaches than I will describe.",
                    "label": 0
                },
                {
                    "sent": "Our method then I will conclude with results on some future work.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, why do we want to estimate drug target predict interactions?",
                    "label": 0
                },
                {
                    "sent": "Because we can modulate functions of the proteins using drugs and we have two information sources.",
                    "label": 0
                },
                {
                    "sent": "We have a growing knowledge of chemical space of drugs and genomic space of proteins due to high throughput screening assays and also high throughput genomic projects.",
                    "label": 1
                },
                {
                    "sent": "But the problem is that we have a limited knowledge about relationship between these two spaces.",
                    "label": 0
                },
                {
                    "sent": "And This is why we need some computational methods for this prediction problem.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And also another problem is that we have some existing databases, but these databases only contains contain experimentally validated interactions.",
                    "label": 1
                },
                {
                    "sent": "And of course these are.",
                    "label": 0
                },
                {
                    "sent": "These contain missing interactions and that's why we need computational methods for identifying interactions, and this will bring 2 advantages.",
                    "label": 1
                },
                {
                    "sent": "First, we can guide biologists towards new predictions, or we can provide supporting evidence for their experimental results.",
                    "label": 1
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, basically traditional approaches can be categorized into three main groups.",
                    "label": 0
                },
                {
                    "sent": "First one is knocking simulations, but this hasn't disadvantage of structural information requirements and for some protein families we don't have these in formation and that's why this is not applicable to all proteins.",
                    "label": 0
                },
                {
                    "sent": "And the second category is ligand based approaches and is in this approach we have to have a significant number of.",
                    "label": 1
                },
                {
                    "sent": "The interactions for each target protein and this may not be possible for all proteins, and the third one literature takes mining an.",
                    "label": 1
                },
                {
                    "sent": "In this approach we can only predict interactions that are.",
                    "label": 0
                },
                {
                    "sent": "Validated in biological publications and the other thing is other problem for this approach is that most of the time they use different naming practices.",
                    "label": 0
                },
                {
                    "sent": "So it is very hard to mine these textual data.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And that's why we have machine learning methods for this problem, and we have three input sources, input data sources for these algorithms.",
                    "label": 0
                },
                {
                    "sent": "The first one is chemical properties of drugs and the second one is genomic properties of target proteins, and we also have a partial knowledge about the interaction network.",
                    "label": 1
                },
                {
                    "sent": "We only know experimentally validated interactions.",
                    "label": 0
                },
                {
                    "sent": "And most of the machine learning algorithms have these underlying hypothesis.",
                    "label": 0
                },
                {
                    "sent": "Similar drug compounds are likely to interact with similar target proteins, and I underline these similar words because these similarities can be encoded using kernel functions because kernel functions mean they solve formulating similarities.",
                    "label": 1
                },
                {
                    "sent": "And if you have two kernel functions, one of them for drugs and one of the other one is for.",
                    "label": 0
                },
                {
                    "sent": "Proteins we can easily model the similarities.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, in this Saturday we used four important protein families.",
                    "label": 1
                },
                {
                    "sent": "These are enzymes, ion channels G protein coupled receptors are nuclear receptors.",
                    "label": 0
                },
                {
                    "sent": "These four protein families are particularly particularly important because they are mostly related to diseases and we will solve these interaction prediction problem for these four important families.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And we used for data sets from an earlier study and.",
                    "label": 0
                },
                {
                    "sent": "The largest one is enzyme data set, and it contains more than 400 trucks and more than 600 proteins and smallest one is nuclear receptors.",
                    "label": 0
                },
                {
                    "sent": "It contains 54 drugs and 26 proteins and if you look at the number of interactions it changed with the database.",
                    "label": 1
                },
                {
                    "sent": "But if you look at the ratio of interactions ratio of the experimental validated interactions to the total possible number of interactions, we see that.",
                    "label": 1
                },
                {
                    "sent": "Enzyme data set has possibly quote more than quarter million interactions and we only know 3000 of them.",
                    "label": 0
                },
                {
                    "sent": "An it corresponds to around 1% and for the nickel receptors, the experimental validates the interactions amount to almost 7%, and as you can see, these interaction networks are very sparse.",
                    "label": 0
                },
                {
                    "sent": "OK.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So as I mentioned earlier, we have three information sources.",
                    "label": 0
                },
                {
                    "sent": "The first one is drugs and for the drugs we have very basic similarity function which is called SIM comp and it basically represents the drugs.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "As graphs and we had a fixed set of substructures, we have fixed Dictionary of substructures and they look for these substructures in each track and at the end we can represent each track as a binary vector, whether each at each position we have binary values.",
                    "label": 1
                },
                {
                    "sent": "Whether these substructure exist in this drug or not and at the end we can have two binary vectors.",
                    "label": 0
                },
                {
                    "sent": "When we are calculating the similarity between two drugs.",
                    "label": 0
                },
                {
                    "sent": "And the similarity between two dots is the number of the ratio of common substructures.",
                    "label": 0
                },
                {
                    "sent": "Basically this similarity gives us score between zero and one.",
                    "label": 0
                },
                {
                    "sent": "And of course the similarity between the same drugs, the similarity.",
                    "label": 0
                },
                {
                    "sent": "Is equal to 1 an if they don't have any common substructure, the similarity will be 0.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And the second you formation sources genomic data.",
                    "label": 0
                },
                {
                    "sent": "We have target proteins and again we are using second space similarity because sequence space similarity can be calculated for each protein family.",
                    "label": 0
                },
                {
                    "sent": "It is the most basic simulator.",
                    "label": 0
                },
                {
                    "sent": "Tehran.",
                    "label": 0
                },
                {
                    "sent": "In this study we used Smith Waterman scored and in this similarity measure proteins are represented as.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And we know it sequences.",
                    "label": 0
                },
                {
                    "sent": "For example, each protein has citrulline consisting of these 20 letters for amino acids, and attend the similarity between two proteins can be calculated as.",
                    "label": 1
                },
                {
                    "sent": "The normalized Symmetry Waterman score, and again this similarity score will give us a value between zero and one if they are perfectly similar.",
                    "label": 0
                },
                {
                    "sent": "This will be one, and if they are not similar at all this will be 0.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And the 30 formation source may be the most informative one.",
                    "label": 0
                },
                {
                    "sent": "Is the interaction data network and we have and the drugs an anti targets.",
                    "label": 0
                },
                {
                    "sent": "And we have two sets of objects and at the end we are given a set of experimental validated interactions.",
                    "label": 0
                },
                {
                    "sent": "We represent these network as a binary adjacency matrix and each entry is plus one.",
                    "label": 0
                },
                {
                    "sent": "If the corresponding tracker is interacting with the corresponding target protein and minus one otherwise, I am using this plus 1 -- 1 because we will be modeling the problem as a binary classification problem.",
                    "label": 0
                },
                {
                    "sent": "But for example, if you remember the keynote from yesterday, it is also possible to formulate this problem as a one class classification problem, But in this current work we formulate the problem as binary classification problem.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And Atlantis, we have a computational model we want to achieve 2 main goals.",
                    "label": 0
                },
                {
                    "sent": "The first one is we want to be able to.",
                    "label": 0
                },
                {
                    "sent": "Do out of sample predictions.",
                    "label": 0
                },
                {
                    "sent": "For example, if you are given a new drug, we want to estimate the interacting proteins from the training data.",
                    "label": 1
                },
                {
                    "sent": "Or if you are given a new target protein, we want to estimate interacting tracks from the training data.",
                    "label": 0
                },
                {
                    "sent": "Or the hardest problem is that we are given a new drug and then you target protein which are not seen during trainings and we want to estimate the interaction.",
                    "label": 0
                },
                {
                    "sent": "Or between these two objects, this is the hardest case, of course.",
                    "label": 0
                },
                {
                    "sent": "Out of these three and second prediction problem is that we want to complete this given interaction in network because we only know the experimentally validated interactions which may not be complete and we want to fill this matrix.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, I would like to briefly mention previous machine learning approaches.",
                    "label": 0
                },
                {
                    "sent": "The first one is pairwise kernel methods.",
                    "label": 1
                },
                {
                    "sent": "In these methods we have two similarity functions.",
                    "label": 0
                },
                {
                    "sent": "Chemical similarity between drugs and genomic similarity between targets and.",
                    "label": 1
                },
                {
                    "sent": "We basically describer pairwise kernel function between drug target pairs and we do standard kernel based classification or regression.",
                    "label": 0
                },
                {
                    "sent": "It doesn't matter if you have a kernel function between pairs an if you have the target output we can do any regulation or binary classification, But the problem is that we have too many pairs.",
                    "label": 1
                },
                {
                    "sent": "For example, if you have anti drug anti proteins we have this many.",
                    "label": 0
                },
                {
                    "sent": "Possible pairs and we have these storage complex tatiane this quaranti square an if you use standard kernel methods we will have these Andy Coop anti crypto time complexity.",
                    "label": 0
                },
                {
                    "sent": "You remember the enzyme data set.",
                    "label": 0
                },
                {
                    "sent": "We have quarter million possible pairs, which corresponds to training a kernel based algorithm which has quarter million training data.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And the second approach is bipartite graph inference.",
                    "label": 1
                },
                {
                    "sent": "Basically, these methods Maps drugs and target proteins into a common subspace called parallel park pharmacological space an in this space.",
                    "label": 1
                },
                {
                    "sent": "We calculated distance or similarity between drugs and target pairs an.",
                    "label": 0
                },
                {
                    "sent": "For example, if the distance between a particular pair is smaller than a threshold, we label them as interacting.",
                    "label": 1
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And the third approach is matrix factorization methods.",
                    "label": 1
                },
                {
                    "sent": "These methods are.",
                    "label": 1
                },
                {
                    "sent": "Basically used for recommender systems.",
                    "label": 0
                },
                {
                    "sent": "For example, if you know, do a popular Netflix movie recommendation.",
                    "label": 0
                },
                {
                    "sent": "Problem, the idea is we have users and we have items and some users rated some items and we have a partial rating matrix and we want to complete this rating matrix.",
                    "label": 0
                },
                {
                    "sent": "But the problem is that.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "We cannot do out of sample prediction in a simple sense.",
                    "label": 0
                },
                {
                    "sent": "For example, if you have this many users and this many movies and this is the incomplete rating matrix and we want to feel this question marks with our predictions, this is possible using traditional matrix factorization methods.",
                    "label": 1
                },
                {
                    "sent": "But when we have any users or anything.",
                    "label": 0
                },
                {
                    "sent": "Movie we cannot estimate the ratings because we don't have any latent components for NIV movie or NIV users.",
                    "label": 0
                },
                {
                    "sent": "And in that case this problem.",
                    "label": 0
                },
                {
                    "sent": "This formulation can solve one of the prediction problems, but cannot solve out of sample prediction.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, and this lights is the main slide that explains our proposed method.",
                    "label": 1
                },
                {
                    "sent": "Basically we have three information sources and drug kernel, protein, kernel and interaction network given interaction, network and the first we need a projection matrix that Maps these drugs into a low dimensional space and we need another projection mattress for the proteins and again we mapped onto the same low dimensional space.",
                    "label": 1
                },
                {
                    "sent": "And at that, that product inner products between drugs and proteins will give us predicted output and we have another binary classification step after the score calculation.",
                    "label": 0
                },
                {
                    "sent": "And basically I can summarize the method as a hybrid method which is composed of three main elements.",
                    "label": 0
                },
                {
                    "sent": "The first one is kernel based nonlinear dimensionality reduction.",
                    "label": 1
                },
                {
                    "sent": "We have two kernels and we are doing kernel based dimensionality reduction.",
                    "label": 0
                },
                {
                    "sent": "In in part A and we have a matrix factorization model in Part B, an import CV have a binary classification model and at that this will solve interaction prediction problem as a binary classification task.",
                    "label": 0
                },
                {
                    "sent": "Anne.",
                    "label": 0
                },
                {
                    "sent": "What if we are given a new drug?",
                    "label": 0
                },
                {
                    "sent": "Basically, if you are given an IV drug, this corresponds to a new column to this drug kernel matrix and we can calculate a new column for these latent right components than we can take the product between these column and these metrics and we can easily calculate the prediction scores between all possible protein drug pairs.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "OK, this is a graphical and probabilistic model for the algorithm.",
                    "label": 0
                },
                {
                    "sent": "I am only showing.",
                    "label": 0
                },
                {
                    "sent": "Drug part because it is symmetric and we have the same model on the other side with different model parameters and the basic point here is that we have only gamma distribution and normal distribution which are standard probability distributions and and as we will see next doing inference for this model is very easy because of these full conjugacy.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And the exact inference for this probabilistic model is intractable.",
                    "label": 1
                },
                {
                    "sent": "We can use of course, very simple Gibbs sampling approach, But this is computationally expensive.",
                    "label": 0
                },
                {
                    "sent": "An instead with if we follow the different approach and use the variational bias approximation.",
                    "label": 0
                },
                {
                    "sent": "And basically we are using a lower bound on the marginal likelihood using some ansamble of post.",
                    "label": 1
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Terriers are basically we use the mean field approximation we.",
                    "label": 0
                },
                {
                    "sent": "Interpret all random variables and latent variables as different posteriors and attempt we have model parameters and these.",
                    "label": 0
                },
                {
                    "sent": "Latent components for our model and we are using these Yongsan senior quality too.",
                    "label": 0
                },
                {
                    "sent": "Find that.",
                    "label": 0
                },
                {
                    "sent": "Find find it or put bound for these marginal likelihood lower bound for the sorry lower bound for the marginal life quote.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I am displaying these equations because maybe this is too technical, but you can find the details in the paper, but the basic method basic idea is that we have closed form update equations for all of.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Model parameters an AT and we have a very simple procedure we are updating at each iteration we are updating track related the rivals.",
                    "label": 0
                },
                {
                    "sent": "Rotate related variables and interaction scores and at the end we will have these model parameters after convergence.",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, I will.",
                    "label": 0
                },
                {
                    "sent": "I didn't give details about 3 experimental scenarios.",
                    "label": 1
                },
                {
                    "sent": "The first one is exploratory data analysis.",
                    "label": 1
                },
                {
                    "sent": "This can be used by biologists to do some analysts on the given interaction network.",
                    "label": 1
                },
                {
                    "sent": "The second one is doing predictions for out of sample drugs and the third one is predicting unknown interactions completing the missing edges.",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "OK, if you look at the interaction.",
                    "label": 0
                },
                {
                    "sent": "Good enough for 2 dimensional case.",
                    "label": 0
                },
                {
                    "sent": "This is nuclear receptor data set which is the smallest data set that we used becausw.",
                    "label": 0
                },
                {
                    "sent": "We use this for visualization because it has few samples and it is easy to visualize and if you look at the two dimensional embedding, this is basically a by part.",
                    "label": 0
                },
                {
                    "sent": "This should be a bipartite graph and we don't use this prior information and at the end we see that our algorithm is able to capture this bipartite.",
                    "label": 0
                },
                {
                    "sent": "Nature because on one side we have drugs and on the other side we have proteins and this dashed line is the interactions in the training data and these fault lines are the predicted once out of our embedding.",
                    "label": 0
                },
                {
                    "sent": "This is also same for.",
                    "label": 0
                },
                {
                    "sent": "Out of sample prediction for proteins, you should notice that this is an arbitrary rotation.",
                    "label": 0
                },
                {
                    "sent": "We can easily rotate and find a similar graph like this.",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, there are some important observations.",
                    "label": 1
                },
                {
                    "sent": "First, our algorithm successfully captures the bipartite nature.",
                    "label": 1
                },
                {
                    "sent": "We didn't give this specific information to the algorithm, but as a result of the influence we found out, we find that the resulting embedding is a bipartite graph, and dashed lines are connected.",
                    "label": 0
                },
                {
                    "sent": "Connect nearby drugs, which is reasonable and also out of sample held out.",
                    "label": 0
                },
                {
                    "sent": "Interactions are.",
                    "label": 0
                },
                {
                    "sent": "Observed for nearby proteins.",
                    "label": 0
                },
                {
                    "sent": "This may not be enough for prediction because we are using 2 dimensions, but this can be used for exploratory data analysis by biologists.",
                    "label": 1
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "OK, we also did some out of sample prediction using five replications of five 5 fold cross validation and we see that our algorithm.",
                    "label": 0
                },
                {
                    "sent": "I was significantly better on two datasets, especially on ion channels and G protein coupled receptors around 10% and 5% in terms of area under the Roc curve and the results are similar for also area under the precision recall curve.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And also we did some experiments to see the effect of the number of latent dimensions.",
                    "label": 0
                },
                {
                    "sent": "We changed the number of dimensions from 5 to 25.",
                    "label": 0
                },
                {
                    "sent": "As you can see, for the smallest network for the nuclear receptor data set, the dimensionality is not important because the network is so small even with five dimensions we get a good area under the curve value, but for the other data set.",
                    "label": 0
                },
                {
                    "sent": "Performance improved.",
                    "label": 0
                },
                {
                    "sent": "Then we increase the number of dimensions.",
                    "label": 0
                },
                {
                    "sent": "We didn't exploit this idea, but we have a full Bayesian model.",
                    "label": 0
                },
                {
                    "sent": "We can also learn the optimal number of latent dimensions using automatic relevance determination and we will investigate this issue later.",
                    "label": 1
                }
            ]
        },
        "clip_29": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, maybe the most important part of the experiment is this predicting unknown interactions of a given network, because for example, for the enzyme data set we have 3000 experimental validated interactions out of quarter million possible interactions, and we did an experiment like this.",
                    "label": 0
                },
                {
                    "sent": "We train our model for the given interaction network and we rank noninteracting drug target pace with respect to.",
                    "label": 1
                },
                {
                    "sent": "Predictions, of course, and we check predicted interactions manually from latest online versions of these three databases, and we see that if you pick top five predicted interactions for each data set, we see that 16 out of 20 predictions is reported in at least one.",
                    "label": 1
                }
            ]
        },
        "clip_30": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Database, as I mentioned earlier, for example for the enzyme data set, we have 3000 interactions.",
                    "label": 0
                },
                {
                    "sent": "Experimental validates the interactions and we have this many non interacting pairs and if we rank this calls for these noninteracting kuansan.",
                    "label": 0
                },
                {
                    "sent": "If you look at the top five we see that four of them are reported in this in at least one of these databases.",
                    "label": 0
                },
                {
                    "sent": "And the table is very similar for the other datasets.",
                    "label": 0
                },
                {
                    "sent": "Also an you can find you can find others tables in the paper.",
                    "label": 0
                }
            ]
        },
        "clip_31": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "OK, in order to someone to summarize our.",
                    "label": 0
                },
                {
                    "sent": "Contribution we have a novel Bayesian formulation, which is the first fully probabilistic formulation for this problem.",
                    "label": 1
                },
                {
                    "sent": "Basically, it combines three basic machine learning algorithm in a principled manner and we have a.",
                    "label": 1
                },
                {
                    "sent": "We had empirical evidence on 4 drug target interaction networks.",
                    "label": 0
                }
            ]
        },
        "clip_32": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And we had a very efficient variational approximation.",
                    "label": 1
                },
                {
                    "sent": "For example, for the enzyme data set, it takes minutes to find the model parameters and met up implementation is available on my website.",
                    "label": 0
                },
                {
                    "sent": "And for the future work we are planning to extend the model for multiple data sources.",
                    "label": 0
                },
                {
                    "sent": "For example, we can use.",
                    "label": 0
                },
                {
                    "sent": "Different chemical descriptors for drugs and, for example, we can also include structural descriptors for target proteins, and that's it.",
                    "label": 1
                },
                {
                    "sent": "Thank you very much.",
                    "label": 0
                },
                {
                    "sent": "Thank you very much so we have time for a few questions.",
                    "label": 0
                },
                {
                    "sent": "This.",
                    "label": 0
                },
                {
                    "sent": "In practice, there are many situations out of sample predictions and missing interaction directions.",
                    "label": 0
                },
                {
                    "sent": "As you mentioned in this right in this talk.",
                    "label": 0
                },
                {
                    "sent": "So I think you should perform cross validations.",
                    "label": 0
                },
                {
                    "sent": "Which is designed for each stations.",
                    "label": 0
                },
                {
                    "sent": "OK, you mean you mean leave one out prediction right?",
                    "label": 0
                },
                {
                    "sent": "But in this talk you should only one.",
                    "label": 0
                },
                {
                    "sent": "OK, let me show you the game.",
                    "label": 0
                },
                {
                    "sent": "Yeah, how did you split direct target peers?",
                    "label": 0
                },
                {
                    "sent": "OK here between here.",
                    "label": 0
                },
                {
                    "sent": "Basically I am leaving 20% of the drugs out for each replication.",
                    "label": 0
                },
                {
                    "sent": "I am basically discarding 20% of the rolls out for training data an I'm training the model done doing the prediction for the whole missing rows.",
                    "label": 0
                },
                {
                    "sent": "It is harder than live on out prediction because I am missing whole rows instead of single entries.",
                    "label": 0
                },
                {
                    "sent": "If you look at these good off, let me show you.",
                    "label": 0
                },
                {
                    "sent": "OK, this is.",
                    "label": 0
                }
            ]
        },
        "clip_33": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Our training interaction network and for cross validation I am cutting 20% of these metrics out an I'm doing training for the remaining 80% and I'm going to prediction for the remaining 20%.",
                    "label": 0
                },
                {
                    "sent": "Thank you, OK. OK, so there's one more question.",
                    "label": 0
                },
                {
                    "sent": "For the similarity between proteins, you're just using sequence, yes?",
                    "label": 0
                },
                {
                    "sent": "I wonder in their approaches where folks have used structure information.",
                    "label": 0
                },
                {
                    "sent": "The proteins.",
                    "label": 0
                },
                {
                    "sent": "So I was wondering if you were to compare for the subset of proteins for which.",
                    "label": 0
                }
            ]
        },
        "clip_34": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Structure is available if you could compare your method versus using 3D structure to determine how much you missing when you do not use structure information.",
                    "label": 0
                },
                {
                    "sent": "Yes, exactly this is one of our future plans.",
                    "label": 0
                },
                {
                    "sent": "For example, for these datasets.",
                    "label": 0
                },
                {
                    "sent": "Unfortunately for these, for example, G protein coupled receptors.",
                    "label": 0
                },
                {
                    "sent": "We don't have most for most of them we don't have the structure information as you suggested.",
                    "label": 0
                },
                {
                    "sent": "For some of them we have the structure information and we can get a subset of these datasets.",
                    "label": 0
                },
                {
                    "sent": "And do the prediction using structural information.",
                    "label": 0
                },
                {
                    "sent": "Yes, and this is one of our future plans.",
                    "label": 0
                },
                {
                    "sent": "Would it be possible to include also side effect information and through your approach?",
                    "label": 0
                },
                {
                    "sent": "It is not very easy cause for the side effect I guess we should have a proper kernel function an if you have a.",
                    "label": 0
                },
                {
                    "sent": "If we can device a good kernel function.",
                    "label": 0
                },
                {
                    "sent": "Yes of course and.",
                    "label": 0
                },
                {
                    "sent": "Instead of using a single.",
                    "label": 0
                },
                {
                    "sent": "Instead of using a single kernel for drugs, we can include multiple ones and also for the same for proteins.",
                    "label": 0
                },
                {
                    "sent": "Yes, we can include, but we should have a good kernel function for this.",
                    "label": 0
                },
                {
                    "sent": "OK um.",
                    "label": 0
                },
                {
                    "sent": "So maybe just a comprehension questions.",
                    "label": 0
                },
                {
                    "sent": "What was it anyway?",
                    "label": 0
                },
                {
                    "sent": "So how does it scale with the number of factors which you have?",
                    "label": 1
                },
                {
                    "sent": "So just sort of computational complexity.",
                    "label": 0
                },
                {
                    "sent": "OK, basically, computational complexity of our algorithm depends on these matrix inversion an if you look at these are our AP is only in one of these inversions.",
                    "label": 0
                },
                {
                    "sent": "Basically linearly scales with the number of latent components.",
                    "label": 1
                },
                {
                    "sent": "An if, for example, if you have these results for five components and 25 components.",
                    "label": 1
                },
                {
                    "sent": "And the time required for 25 component is almost five times OK of the time required for five components.",
                    "label": 0
                },
                {
                    "sent": "It's case linearly with the number of components and the original question was so, so the negative labeled data.",
                    "label": 0
                },
                {
                    "sent": "So that's that's known to not interact.",
                    "label": 1
                },
                {
                    "sent": "Well, that is not known to interact, so that's actually they are not known to interact, but we interpret them as negatively labeled.",
                    "label": 0
                },
                {
                    "sent": "But as I mentioned earlier, we are using your matrix factorization model, and we can easily.",
                    "label": 0
                },
                {
                    "sent": "Use.",
                    "label": 0
                },
                {
                    "sent": "Damn as missing data and we can only concentrate on the known interactions.",
                    "label": 0
                },
                {
                    "sent": "We also tried this approach and area under the curve.",
                    "label": 0
                },
                {
                    "sent": "Values are very similar.",
                    "label": 0
                },
                {
                    "sent": "Basically it doesn't hurt to include them as negatively labeled data.",
                    "label": 0
                },
                {
                    "sent": "Good, OK, let's thank the speaker again.",
                    "label": 0
                }
            ]
        }
    }
}